is semaglutide a good weight loss drug vs. Other Medications Explained Weight loss drug could reduce

90 , 832S837S (2009)

Both semaglutide and tirzepatide are FDA-approved GLP-1 receptor agonists for weight loss, but clinical evidence shows they work through slightly different mechanisms and produce varied individual outcomes

Beyond that: Consider Tirzepatide If: You want an FDA-approved, commercially available medication You have type 2 diabetes (Mounjaro is specifically approved for this) You prefer a medication with more long-term safety data Your insurance covers tirzepatide You need predictable access to medication supply Consider Waiting for Retatrutide If: You've plateaued on other GLP-1 medications You're interested in the potential metabolic benefits of glucagon activation You're comfortable waiting for FDA approval (expected 2027) You want potentially greater fat loss based on early trial data Switching From Tirzepatide to Retatrutide No established dose conversion exists

With obesity, there are just so many patients, says Krista Mistovich, Pharm.D., a pharmacist who works in managed care